Steve Frey

Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors

Timothy A. Yap, Jane N. Winter, Lisa Giulino‐Roth et al. · Clinical Cancer Research · 2019 · 159 citations · Full text

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

Eric L. Simpson, Robert Bissonnette, Lawrence F. Eichenfield et al. · Journal of the American Academy of Dermatology · 2020 · 159 citations

Reliability, Engineering, Atopic Dermatitis +8

Structural and Functional Definition of the Human Chitinase Chitin-binding Domain

Larry W. Tjoelker, Larry Gosting, Steve Frey et al. · Journal of Biological Chemistry · 2000 · 147 citations · Full text

A Dose-Ranging Study of a Prototype Synthetic HIV-1MN V3 Branched Peptide Vaccine

Geoffrey J. Gorse, M. C. Keefer, Robert B. Belshe et al. · The Journal of Infectious Diseases · 1996 · 67 citations

Vaccination, Mn Strain, Vaccine Development +13

Impact of Body Mass Index on Immunogenicity of Pandemic H1N1 Vaccine in Children and Adults

S. Todd Callahan, Mark Wolff, Heather R. Hill et al. · The Journal of Infectious Diseases · 2014 · 51 citations · Full text

Immunology, Flu Vaccination, Vaccine Hesitancy +16